CA
BBIO icon

Cliff Asness’s BridgeBio Pharma BBIO Stock Holding History

Cliff Asness’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.4M Buy
166,949
+6,837
+4% +$479K ﹤0.01% 1436
2026
Q1 		$11.9M Buy
160,112
+25,595
+19% +$1.86M 0.01% 1254
2025
Q4 		$10.3M Buy
134,517
+35,690
+36% +$2.34M 0.01% 1205
2025
Q3 		$5.13M Sell
98,827
-58,978
-37% -$2.88M ﹤0.01% 1441
2025
Q2 		$6.81M Buy
157,805
+23,548
+18% +$856K 0.01% 1125
2025
Q1 		$4.64M Sell
134,257
-89,316
-40% -$3.01M ﹤0.01% 1158
2024
Q4 		$6.13M Buy
223,573
+27,610
+14% +$714K 0.01% 1013
2024
Q3 		$4.99M Buy
195,963
+70,803
+57% +$1.86M 0.01% 1062
2024
Q2 		$3.17M Sell
125,160
-4,800
-4% -$131K ﹤0.01% 1247
2024
Q1 		$4.02M Buy
129,960
+96,926
+293% +$3.3M 0.01% 1073
2023
Q4 		$1.33M Buy
33,034
+10,832
+49% +$325K ﹤0.01% 1499
2023
Q3 		$585K Sell
22,202
-3,622
-14% -$103K ﹤0.01% 1791
2023
Q2 		$444K Buy
+25,824
New +$389K ﹤0.01% 1825
2021
Q4 		– Sell
-15,685
Closed -$735K – 2200
2021
Q3 		$735K Buy
15,685
+7,917
+102% +$424K ﹤0.01% 1706
2021
Q2 		$474K Sell
7,768
-10,122
-57% -$578K ﹤0.01% 1917
2021
Q1 		$1.1M Buy
17,890
+13,989
+359% +$915K ﹤0.01% 1511
2020
Q4 		$277K Sell
3,901
-1,848
-32% -$89.2K ﹤0.01% 1995
2020
Q3 		$216K Sell
5,749
-40,976
-88% -$1.29M ﹤0.01% 2037
2020
Q2 		$1.52M Buy
+46,725
New +$1.42M ﹤0.01% 1288

Other funds holding BBIO

JT
Jupiter Topco New York $245B AUM
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

Cliff Asness's BBIO Position: Q2 2026 in Review

Cliff Asness increased its BridgeBio Pharma (BBIO) stake by 4.3% in Q2 2026, buying an estimated $479K and bringing the position to 166,949 shares worth $12.4M. The position accounts for ﹤0.01% of the portfolio, ranked #1436.

Cliff Asness first reported a position in BBIO in Q2 2020 and has held it in 19 quarters since. 471 funds tracked by Wall St. Rank hold BBIO as of Q2 2026.

  • Cliff Asness held 166,949 shares of BridgeBio Pharma worth $12.4M as of Q2 2026.
  • Cliff Asness bought 6,837 BridgeBio Pharma shares in Q2 2026, an estimated $479K.
  • BridgeBio Pharma made up ﹤0.01% of Cliff Asness's portfolio in Q2 2026, its #1436 holding.
  • Cliff Asness first reported a position in BridgeBio Pharma in Q2 2020 and has held it in 19 quarters since.
  • 471 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.